Skip to main content

Published locations for FDA extends Dupixent indication for 12- to 17-year-olds

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA extends Dupixent indication for 12- to 17-year-olds

User login

  • Reset your password
  • /content/fda-extends-dupixent-indication-12-17-year-olds
  • /clinicianreviews/article/196082/atopic-dermatitis/fda-extends-dupixent-indication-12-17-year-olds
  • /edermatologynews/article/196082/atopic-dermatitis/fda-extends-dupixent-indication-12-17-year-olds
  • /familypracticenews/article/196082/atopic-dermatitis/fda-extends-dupixent-indication-12-17-year-olds
  • /pediatricnews/article/196082/atopic-dermatitis/fda-extends-dupixent-indication-12-17-year-olds
  • /pediatrics/article/196082/atopic-dermatitis/fda-extends-dupixent-indication-12-17-year-olds
  • /dermatology/article/196082/atopic-dermatitis/fda-extends-dupixent-indication-12-17-year-olds
  • /familymedicine/article/196082/atopic-dermatitis/fda-extends-dupixent-indication-12-17-year-olds